Kevin M. Lalande, Director at LUMOS PHARMA, INC. (LUMO), bought 24,400 shares at $11.23 ($274K) on 2021-09-02, disclosed to the SEC on 2021-09-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.23 | 6,300 | $71K | 25.8% |
| 2 | $11.35 | 8,100 | $92K | 33.6% |
| 3 | $11.11 | 10,000 | $111K | 40.6% |
| Total | $11.22 avg | 24,400 | $274K | 100% |
| Filing → |
| LUMO | BUY | 2021-09-01 | $269K | — | Filing → |
| LUMO | BUY | 2021-08-27 | $314K | — | Filing → |
| LUMO | BUY | 2021-08-24 | $1.2M | — | Filing → |